form8k-109626_bcp.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
report (date of earliest event reported): August 3, 2010
Balchem
Corporation
(Exact
name of registrant as specified in its charter)
Maryland
|
1-13648
|
13-2578432
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
New
Hampton, NY 10958
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (845) 326-5600
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results of Operations and Financial Condition
On August
3, 2010, Balchem Corporation, reported earnings for its second quarter ended
June 30, 2010. The full text of the press release issued in connection with the
announcement is attached as Exhibit 99.1.
The
information in this Form 8-K (including Exhibit 99.1) shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
Item 9.01
Financial Statements and Exhibits
(c)
Exhibits.
99.1 Press
Release of Balchem Corporation, dated August 3, 2010, reporting its financial
results for the second quarter of 2010.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
BALCHEM
CORPORATION
|
|
|
|
|
|
By:/s/ Francis J.
Fitzpatrick
|
|
Francis
J. Fitzpatrick
|
|
Chief
Financial Officer
|
Dated:
August 3, 2010
Exhibit
Index
Exhibit
Number Description
99.1
|
Press
Release of Balchem Corporation, dated August 3,
2010
|